Elanco Animal Health Incorporated (ELAN)

Elanco Animal Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	4,484	4,439	4,417	4,411	4,764	3,271
Revenue Growth (YoY)	-0.18%	0.50%	0.14%	-7.41%	45.64%	6.51%
Cost of Revenue	2,030	2,003	1,931	1,913	2,068	1,577
Gross Profit	2,454	2,436	2,486	2,498	2,696	1,694
Selling, General & Admin	1,358	1,308	1,280	1,259	1,395	988
Research & Development	354	344	327	321	369	329
Amortization of Goodwill & Intangibles	527	527	548	528	556	360
Operating Expenses	2,239	2,179	2,155	2,108	2,320	1,677
Operating Income	215	257	331	390	376	17
Interest Expense	-192	-235	-277	-241	-236	-150
Currency Exchange Gain (Loss)	18	-12	-40	-28	-35	-4
Other Non Operating Income (Expenses)	-54	-12	-12.5	-10	22	-60
EBT Excluding Unusual Items	-13	-2	1.5	111	127	-197
Merger & Restructuring Charges	-4	-62	-93	-98	-336	-702
Impairment of Goodwill	-	-	-1,042	-	-	-
Gain (Loss) on Sale of Investments	-	-	-	-	-	11
Gain (Loss) on Sale of Assets	640	640	-	-	-	211
Asset Writedown	-20	-81	-32	-81	-	-
Legal Settlements	-	-	-27.5	-	-10	-
Other Unusual Items	-10	-7	-2	-4	-352	-
Pretax Income	593	488	-1,195	-72	-571	-677
Income Tax Expense	159	150	36	6	-88	-103
Net Income	434	338	-1,231	-78	-483	-574
Net Income to Common	434	338	-1,231	-78	-483	-574
Shares Outstanding (Basic)	495	494	492	488	487	441
Shares Outstanding (Diluted)	500	497	492	488	487	441
Shares Change (YoY)	1.42%	1.02%	0.82%	0.23%	10.38%	19.20%
EPS (Basic)	0.88	0.68	-2.50	-0.16	-0.99	-1.30
EPS (Diluted)	0.88	0.68	-2.50	-0.16	-0.99	-1.30
Free Cash Flow	361	394	131	281	324	-176
Free Cash Flow Per Share	0.72	0.79	0.27	0.57	0.67	-0.40
Gross Margin	54.73%	54.88%	56.28%	56.63%	56.59%	51.79%
Operating Margin	4.79%	5.79%	7.49%	8.84%	7.89%	0.52%
Profit Margin	9.68%	7.61%	-27.87%	-1.77%	-10.14%	-17.55%
Free Cash Flow Margin	8.05%	8.88%	2.97%	6.37%	6.80%	-5.38%
EBITDA	842	879	971	1,007	1,040	499
EBITDA Margin	18.78%	19.80%	21.98%	22.83%	21.83%	15.25%
D&A For EBITDA	627	622	640	617	664	482
EBIT	215	257	331	390	376	17
EBIT Margin	4.79%	5.79%	7.49%	8.84%	7.89%	0.52%
Effective Tax Rate	26.81%	30.74%	-	-	-	-
Advertising Expenses	-	236	207	201	248	-

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q